Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study

Area of Science:

• Neurology
• Cardiovascular Medicine
• Pharmacology

Background:

• Statins are known to reduce stroke risk through lipid lowering and antiatherothrombotic effects.
• Statins also possess neuroprotective properties relevant to stroke.
• Previous research focused on stroke prevention, with limited data on outcomes once stroke occurs.

Purpose of the Study:

• To investigate if statin treatment improves clinical outcomes in patients experiencing a stroke.
• To explore the association between statin use at stroke onset and early discharge to home.

Main Methods:

• A population-based case-referent study design was employed.
• Included stroke patients aged 25-74 years.
• Cases were patients on statins at stroke onset (n=125); referents were matched patients not on statins (n=250).

Main Results:

• Unadjusted odds ratio for early discharge to home among statin users was 1.41 (95% CI 0.91 to 2.17).
• Patients on statins generally had more unfavorable prognostic factors.
• After logistic regression adjustment, statin use remained a non-significant predictor of discharge to home (OR 1.42, 95% CI 0.90 to 2.22).

Conclusions:

• The study lacked statistical power to confirm moderate beneficial effects of statins in acute stroke.
• An observed positive trend suggests further research is needed.
• Experimental data supports continued investigation into statins' role in stroke outcome.